NATCAPSUQPharmaceuticals
Natural Capsules Ltd — Cash Flow Statement
₹144.35
-2.36%
Natural Capsules Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -17.88 Cr | -79.98 Cr | -88.67 Cr | -46.60 Cr | — |
| Repayment Of Debt | -5.19 Cr | 0.00 | 0.00 | 0.00 | — |
| Issuance Of Capital Stock | 27.84 Cr | 75.56 Cr | 22.64 Cr | 7.79 Cr | — |
| Capital Expenditure | -44.63 Cr | -71.63 Cr | -105.89 Cr | -46.08 Cr | — |
| End Cash Position | 0.69 Cr | 2.25 Cr | 1.48 Cr | 1.40 Cr | — |
| Beginning Cash Position | 2.25 Cr | 1.48 Cr | 1.40 Cr | 0.10 Cr | — |
| Changes In Cash | -1.57 Cr | 0.78 Cr | 0.08 Cr | 1.30 Cr | — |
| Financing Cash Flow | 16.17 Cr | 81.72 Cr | 87.49 Cr | 47.70 Cr | — |
| Net Other Financing Charges | -1000.00 | — | 25.02 Cr | -1000.00 | — |
| Interest Paid Cff | -6.31 Cr | -5.13 Cr | -3.41 Cr | -1.96 Cr | — |
| Net Common Stock Issuance | 27.84 Cr | 75.56 Cr | 22.64 Cr | 7.79 Cr | — |
| Common Stock Issuance | 27.84 Cr | 75.56 Cr | 22.64 Cr | 7.79 Cr | — |
| Net Issuance Payments Of Debt | -5.19 Cr | 12.46 Cr | 44.27 Cr | 42.64 Cr | — |
| Net Long Term Debt Issuance | -5.19 Cr | 12.46 Cr | 44.27 Cr | 42.64 Cr | — |
| Long Term Debt Payments | -5.19 Cr | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | -44.48 Cr | -72.59 Cr | -104.63 Cr | -45.88 Cr | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | -0.05 Cr | -0.06 Cr | — |
| Net Income From Continuing Operations | 2.79 Cr | 8.05 Cr | 24.99 Cr | 19.39 Cr | — |
| Interest Received Cfi | 0.15 Cr | 0.92 Cr | 0.37 Cr | 0.21 Cr | — |
| Dividends Received Cfi | 0.00 | — | — | 0.00 | 0.00 |
| Net Investment Purchase And Sale | 0.00 | -2.73 Cr | 0.04 Cr | -0.04 Cr | — |
| Sale Of Investment | 0.00 | 0.00 | 0.04 Cr | 0.00 | — |
| Purchase Of Investment | 0.00 | -2.73 Cr | 0.00 | -0.04 Cr | — |
| Net Intangibles Purchase And Sale | 0.00 | 0.63 Cr | 0.63 Cr | -1.74 Cr | — |
| Net PPE Purchase And Sale | -44.63 Cr | -71.41 Cr | -105.67 Cr | -44.30 Cr | — |
| Sale Of PPE | 0.00 | 0.22 Cr | 0.22 Cr | 0.04 Cr | — |
| Purchase Of PPE | -44.63 Cr | -71.63 Cr | -105.89 Cr | -44.34 Cr | — |
| Operating Cash Flow | 26.75 Cr | -8.35 Cr | 17.22 Cr | -0.52 Cr | — |
| Taxes Refund Paid | -2.07 Cr | -1.97 Cr | -5.46 Cr | -4.74 Cr | — |
| Change In Working Capital | 10.08 Cr | -27.98 Cr | -12.58 Cr | -21.42 Cr | — |
| Change In Other Current Liabilities | 9.23 Cr | -7.67 Cr | 2.00 Cr | 2.73 Cr | — |
| Change In Other Current Assets | 6.86 Cr | -9.62 Cr | 3.53 Cr | -26.82 Cr | — |
| Change In Payable | 8.09 Cr | 2.99 Cr | 11.45 Cr | -0.10 Cr | — |
| Change In Inventory | -6.42 Cr | -10.19 Cr | -4.27 Cr | 2.03 Cr | — |
| Change In Receivables | -8.53 Cr | -2.64 Cr | -25.96 Cr | 0.23 Cr | — |
| Other Non Cash Items | 6.17 Cr | 4.21 Cr | 3.03 Cr | 1.31 Cr | — |
| Stock Based Compensation | 0.29 Cr | 0.11 Cr | 0.00 | — | — |
| Depreciation And Amortization | 9.12 Cr | 8.67 Cr | 7.21 Cr | 5.04 Cr | — |
| Amortization Cash Flow | 0.48 Cr | 0.63 Cr | 0.63 Cr | 0.16 Cr | — |
| Depreciation | 8.64 Cr | 8.03 Cr | 6.58 Cr | 4.88 Cr | — |
| Pension And Employee Benefit Expense | -0.39 Cr | 0.26 Cr | -0.06 Cr | -0.20 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.00 | — | — | -0.10 Cr | -0.37 Cr |
| Issuance Of Debt | — | 12.46 Cr | 44.27 Cr | 42.64 Cr | 3.37 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | -5000.00 | 1.00 |
| Cash Dividends Paid | — | -0.93 Cr | -0.77 Cr | -0.62 Cr | -0.37 Cr |
| Long Term Debt Issuance | — | 12.46 Cr | 44.27 Cr | 42.64 Cr | 3.37 Cr |
| Net Other Investing Changes | — | — | -1000.00 | — | -1000.00 |
| Net Short Term Debt Issuance | — | — | — | — | 3.37 Cr |
| Short Term Debt Issuance | — | — | — | — | 3.37 Cr |
| Gain Loss On Investment Securities | — | — | — | — | -2.18 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Natural Capsules Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.